Koyfin Home > Directory > Health Care > Aratana Theraptcs > Gross Margin

Aratana Theraptcs Gross Margin Chart (PETX)

Aratana Theraptcs annual/quarterly Gross Margin from 2013 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Aratana Theraptcs Gross Margin for the quarter ending December 12, 2018 was $27m a -144.96% decrease of -40m year over year
  • Aratana Theraptcs Gross Margin for the last 12 months ending December 12, 2018 was $70m a 46.35% increase of 32m year over year
  • Aratana Theraptcs Annual Gross Margin for 2018 was $70m a 58.82% increase of 41m from 2017
  • Aratana Theraptcs Annual Gross Margin for 2017 was $29m a -218.00% decrease of -63m from 2016
  • Aratana Theraptcs Annual Gross Margin for 2016 was $92m a 63.12% increase of 58m from 2015
Other Margins & Efficiency Metrics:
  • Aratana Theraptcs EBITDA Margin for the quarter ending December 12, 2018 was $-152m a -14.36% increase of 22m year over year
  • Aratana Theraptcs Return on Capital % for the quarter ending September 09, 2018 was 18.29 a 181.73% increase of 33.23 year over year
  • Aratana Theraptcs Return on Equity % for the quarter ending September 09, 2018 was 35.00 a 305.07% increase of 106.77 year over year
View Chart On Koyfin

Quarterly PETX Gross Margin Data

12/2018$27m
09/2018$84m
06/2018$55m
03/2018$67m
12/2017$37m
09/2017$33m
06/2017$22m
03/2017$10m
12/2016$-291m
06/2016$95m

Annual PETX Gross Margin Data

2018$70m
2017$29m
2016$92m
2015$34m
2014$47m
2013$11m